Search Results - "Ørntoft, T F"

Refine Results
  1. 1

    miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors by Ostenfeld, M S, Bramsen, J B, Lamy, P, Villadsen, S B, Fristrup, N, Sørensen, K D, Ulhøi, B, Borre, M, Kjems, J, Dyrskjøt, L, Ørntoft, T F

    Published in Oncogene (18-02-2010)
    “…Downregulation of miR-145 in a variety of cancers suggests a possible tumor suppressor function for this microRNA. Here, we show that miR-145 expression is…”
    Get full text
    Journal Article
  2. 2

    Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma by Dyrskjøt, L, Zieger, K, Kissow Lildal, T, Reinert, T, Gruselle, O, Coche, T, Borre, M, Ørntoft, T F

    Published in British journal of cancer (26-06-2012)
    “…Background: The potential for cancer-testis (CT) antigens as targets for immunotherapy in cancer patients has been heavily investigated, and currently cancer…”
    Get full text
    Journal Article
  3. 3

    Mutations in the TLR3 signaling pathway and beyond in adult patients with herpes simplex encephalitis by Mørk, N, Kofod-Olsen, E, Sørensen, K B, Bach, E, Ørntoft, T F, Østergaard, L, Paludan, S R, Christiansen, M, Mogensen, T H

    Published in Genes and immunity (01-12-2015)
    “…Herpes simplex encephalitis (HSE) in children has previously been linked to defects in type I interferon production downstream of Toll-like receptor (TLR)3. In…”
    Get full text
    Journal Article
  4. 4

    Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer by Sørensen, K D, Abildgaard, M O, Haldrup, C, Ulhøi, B P, Kristensen, H, Strand, S, Parker, C, Høyer, S, Borre, M, Ørntoft, T F

    Published in British journal of cancer (05-02-2013)
    “…Background: Novel biomarkers for prostate cancer (PC) are urgently needed. This study investigates the expression, epigenetic regulation, and prognostic…”
    Get full text
    Journal Article
  5. 5

    Global profiling of genes modified by endoplasmic reticulum stress in pancreatic beta cells reveals the early degradation of insulin mRNAs by Pirot, P, Naamane, N, Libert, F, Magnusson, N. E, Ørntoft, T. F, Cardozo, A. K, Eizirik, D. L

    Published in Diabetologia (01-05-2007)
    “…Aims/hypothesis Pancreatic beta cells respond to endoplasmic reticulum (ER) stress by activating the unfolded protein response. If the stress is prolonged, or…”
    Get full text
    Journal Article
  6. 6

    Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer by Teo, M.T.W., Dyrskjøt, L., Nsengimana, J., Buchwald, C., Snowden, H., Morgan, J., Jensen, J.B., Knowles, M.A., Taylor, G., Barrett, J.H., Borre, M., Ørntoft, T.F., Bishop, D.T., Kiltie, A.E.

    Published in Annals of oncology (01-04-2014)
    “…Muscle-invasive bladder cancer (MIBC) can be cured by radical radiotherapy (RT). We previously found tumour MRE11 expression to be predictive of survival…”
    Get full text
    Journal Article
  7. 7

    A high resolution genomic portrait of bladder cancer: correlation between genomic aberrations and the DNA damage response by Schepeler, T, Lamy, P, Hvidberg, V, Laurberg, J R, Fristrup, N, Reinert, T, Bartkova, J, Tropia, L, Bartek, J, Halazonetis, T D, Pan, C-C, Borre, M, Dyrskjøt, L, Ørntoft, T F

    Published in Oncogene (01-08-2013)
    “…One major challenge in cancer research is to understand the complex interplay between the DNA damage response (DDR), genomic integrity, and tumor development…”
    Get full text
    Journal Article
  8. 8

    Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid by Birkenkamp-Demtroder, K, Olesen, S H, Sørensen, F B, Laurberg, S, Laiho, P, Aaltonen, L A, Ørntoft, T F

    Published in Gut (01-03-2005)
    “…Background and aims: There are epidemiological, morphological, and molecular differences between normal mucosa as well as between adenocarcinomas of the right…”
    Get full text
    Journal Article
  9. 9

    Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer by Andersen, C L, Christensen, L L, Thorsen, K, Schepeler, T, Sørensen, F B, Verspaget, H W, Simon, R, Kruhøffer, M, Aaltonen, L A, Laurberg, S, Ørntoft, T F

    Published in British journal of cancer (10-02-2009)
    “…The aim of this study was to identify deregulated transcription factors (TFs) in colorectal cancer (CRC) and to evaluate their relation with the recurrence of…”
    Get full text
    Journal Article
  10. 10

    Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer by ANDERSEN, J. B, AABOE, M, BORDEN, E. C, GOLOUBEVA, O. G, HASSEL, B. A, ØRNTOFT, T. F

    Published in British journal of cancer (22-05-2006)
    “…Bladder cancer is among the most prevalent malignancies, and is characterised by frequent tumour recurrences and localised inflammation, which may promote…”
    Get full text
    Journal Article
  11. 11

    Induction of nuclear factor-κB and its downstream genes by TNF-α and IL-1β has a pro-apoptotic role in pancreatic beta cells by Ortis, F, Pirot, P, Naamane, N, Kreins, A. Y, Rasschaert, J, Moore, F, Théâtre, E, Verhaeghe, C, Magnusson, N. E, Chariot, A, Ørntoft, T. F, Eizirik, D. L

    Published in Diabetologia (01-07-2008)
    “…Aims/hypothesis IL-1β and TNF-α contribute to pancreatic beta cell death in type 1 diabetes. Both cytokines activate the transcription factor nuclear factor-κB…”
    Get full text
    Journal Article
  12. 12

    intrauterine metabolic environment modulates the gene expression pattern in fetal rat islets: prevention by maternal taurine supplementation by Reusens, B, Sparre, T, Kalbe, L, Bouckenooghe, T, Theys, N, Kruhøffer, M, Ørntoft, T. F, Nerup, J, Remacle, C

    Published in Diabetologia (01-05-2008)
    “…Aims/hypothesis Events during fetal life may in critical time windows programme tissue development leading to organ dysfunction with potentially harmful…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Differential expression of DHHC9 in microsatellite stable and instable human colorectal cancer subgroups by MANSILLA, F, BIRKENKAMP -DEMTRODER, K, KRUHØFFER, M, SØRENSEN, F. B, ANDERSEN, C. L, LAIHO, P, AALTONEN, L. A, VERSPAGET, H. W, ØRNTOFT, T. F

    Published in British journal of cancer (18-06-2007)
    “…Microarray analysis on pooled samples has previously identified ZDHHC9 (DHHC9) to be upregulated in colon adenocarcinoma compared to normal colon mucosa…”
    Get full text
    Journal Article
  15. 15

    Pancreatic β-cells activate a JunB ATF3-dependent survival pathway during inflammation by Gurzov, E N, Barthson, J, Marhfour, I, Ortis, F, Naamane, N, Igoillo-Esteve, M, Gysemans, C, Mathieu, C, Kitajima, S, Marchetti, P, Ørntoft, T F, Bakiri, L, Wagner, E F, Eizirik, D L

    Published in Oncogene (29-03-2012)
    “…Destruction of insulin-producing pancreatic β-cells by local autoimmune inflammation is a hallmark of type 1 diabetes. Histochemical analysis of pancreases…”
    Get full text
    Journal Article
  16. 16

    Low ANXA10 expression is associated with disease aggressiveness in bladder cancer by Munksgaard, P P, Mansilla, F, Brems Eskildsen, A-S, Fristrup, N, Birkenkamp-Demtröder, K, Ulhøi, B P, Borre, M, Agerbæk, M, Hermann, G G, Ørntoft, T F, Dyrskjøt, L

    Published in British journal of cancer (25-10-2011)
    “…Background: Markers for outcome prediction in bladder cancer are urgently needed. We have previously identified a molecular signature for predicting…”
    Get full text
    Journal Article
  17. 17

    Gene expression profiling of noninvasive primary urothelial tumours using microarrays by AABOE, M, MARCUSSEN, N, JENSEN, K. M.-E, THYKJAER, T, DYRSKJØT, L, ØRNTOFT, T. F

    Published in British journal of cancer (14-11-2005)
    “…At present, the mechanism leading to bladder cancer is still poorly understood, and our knowledge about early events in tumorigenesis is limited. This study…”
    Get full text
    Journal Article
  18. 18

    No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia by Raitila, A, Georgitsi, M, Karhu, A, Tuppurainen, K, Mäkinen, M J, Birkenkamp-Demtröder, K, Salmenkivi, K, Ørntoft, T F, Arola, J, Launonen, V, Vahteristo, P, Aaltonen, L A

    Published in Endocrine-related cancer (01-09-2007)
    “…Germline mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene were recently observed in patients with pituitary adenoma predisposition…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Frequency of hereditary non-polyposis colorectal cancer in Danish colorectal cancer patients by Katballe, N, Christensen, M, Wikman, F P, Ørntoft, T F, Laurberg, S

    Published in Gut (01-01-2002)
    “…Background: Hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal dominant cancer syndrome, characterised by familial aggregation of HNPCC related…”
    Get full text
    Journal Article